Elsevier

Annals of Oncology

Volume 22, Supplement 6, September 2011, Pages vi85-vi92
Annals of Oncology

supportive care
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines

https://doi.org/10.1093/annonc/mdr392Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Approved by the ESMO Guidelines Working Group: August 2008, last update March 2011. This publication supersedes the previously published version—Ann Oncol 2010; 21 (Suppl 5): v274-v276.

Conflict of interest: Professor Roila has reported that he is conducting research on prevention of venous thromboembolism sponsored by Sanofi-Aventis. Dr Mandalà has reported membership of Advisory Board and Speakers' Bureau for Sanofi, Clinical trials for thromboprophylaxis by Italfarmaco. Dr. Falanga has reported the following activities in the past two years: member of Pfizer Virtual Advisory board on Fragmin and member of the Adjudication Committee of Sanofi-Aventis Registry Master Oncology.